Bronchial Diseases: Clinical Trials

407 trials for Bronchial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

407 completed. 407 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4407Completed 407

Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases

Trials (filtered) newest first · largest first

All 407 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.
DSP2505(Canium), Umckamin, Placebo Matching Umckamin - Acute Bronchitis
Phase 4CompletedDasan Pharmaceutical Co., Ltd.2232026-01-262026-09-23
IV DEXAMETHASONE VS. METHYLPREDNISOLONE IN CHILDREN WITH SEVERE ASTHMA EXACERBATION
Intravenous Dexamethasone, Intravenous Methylprednisolone - Status Asthmaticus, Asthma (Diagnosis)
Phase 4CompletedIstanbul Medeniyet University1292025-09-012026-07-28
The Use of Cyproheptadine in Pediatric Feeding Disorders
Cyproheptadine, Nutritional Counseling, Behavioral Counseling - Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder
Phase 4CompletedUniversity of Miami182024-12-302026-06-04
A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
Belumosudil - Chronic Graft Versus Host Disease
Phase 4CompletedSanofi62024-12-042026-05-27
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Phase 4CompletedNovartis Pharmaceuticals852024-11-282026-06-08
Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.
Budesonide-Formoterol treatment - Cough-Variant Asthma
Phase 4CompletedAstraZeneca10002024-10-182025-09-18
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
Albuterol/Budesonide, Albuterol - Mild Asthma
Phase 4CompletedAstraZeneca1012024-09-112026-02-27
Evaluation of Time-Sensitive Nebulization Mode Converter
Cross-over Nebulization Modes Comparison System - Aerosol Therapy, Asthma
Phase 4CompletedBeni-Suef University362024-09-012026-06-08
A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients
Mirabegron 100 mg, Mirabegron 50mg, mirabegron 25 mg - Cirrhosis, Asthma
Phase 4CompletedKafrelsheikh University782024-07-012026-04-16
BenRalizumab Effect on Airway Remodeling in Severe asTHma
Benralizumab 30 mg/ml - Asthma; Eosinophilic, Airway Remodeling
Phase 4CompletedAristotle University Of Thessaloniki362024-03-012026-10-28
Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)
Test preparation:Methylcholine chloroacetate for inhalation, Reference preparation:Methylcholine chloroacetate for inhalation(Provocholine) - Asthma
Phase 4CompletedChina-Japan Friendship Hospital402024-02-242024-12-10
Individualizing Treatment for Asthma in Primary Care
Asthma Symptom Monitoring online tools, Inhaled Steroids, Azithromycin Pill - Asthma, Bronchial Diseases
Phase 4CompletedDARTNet Institute1032024-02-012025-04-20
Reversibility of Methacholine Induced Bronchoconstriction
salbutamol aqueous solution, salbutamol pressurized metered dose inhaler, placebo - Asthma
Phase 4CompletedUniversity of Saskatchewan162024-01-122026-05-04
A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children
Salbutamol (Ventolin®), salbutamol + ipratropium bromide nebules - Asthma Exacerbation, Children
Phase 4CompletedChildren's Hospital and Institute of Child Health, Multan602024-01-012025-04-09
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral ciprofloxacin placebo - Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
Phase 4CompletedJin-Fu Xu3712023-10-182026-04-17
A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.
Guafenesin tablets - Chronic Bronchitis
Phase 4CompletedAmerican Health Research822023-07-172026-03-20
Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia
Lidocaine (drug), Saline (NaCl 0,9 %) (placebo) - Upper Respiratory Tract Infections, Perioperative Respiratory Complications
Phase 4CompletedTunis University1022023-01-022024-09-19
ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression
Foster BDP/Formoterol, Omalizimab - Asthma Patients
Phase 4CompletedTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation262023-01-012025-03-11
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging
Benralizumab - Asthma
Phase 4CompletedAstraZeneca452022-10-112025-03-25
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Capmatinib 150 mg, Capmatinib 200 mg - Non-Small Cell Lung Carcinoma
Phase 4CompletedNovartis Pharmaceuticals502022-09-032026-10-26

Showing 20 of 407. Sign in to see all of them.

Narrower conditions

Asthma (308)  ·  Pulmonary Disease, Chronic Obstructive (41)  ·  Bronchiolitis Obliterans Syndrome (34)  ·  Bronchitis (16)  ·  Bronchitis, Chronic (16)  ·  Bronchiectasis (14)  ·  Emphysema (13)  ·  Rhinitis, Allergic (13)  ·  Bronchiolitis (9)  ·  Pulmonary Eosinophilia (8)  ·  Respiratory Hypersensitivity (8)  ·  Respiratory Sounds (8)  ·  Emergencies (7)  ·  Cough (6)  ·  Inflammation (6)

Broader conditions

Respiratory Tract Diseases (405)  ·  Lung Diseases, Obstructive (384)  ·  Lung Diseases (382)  ·  Immune System Diseases (344)  ·  Hypersensitivity, Immediate (314)  ·  Hypersensitivity (312)  ·  Respiratory Hypersensitivity (305)  ·  Pathological Conditions, Signs and Symptoms (93)  ·  Pathologic Processes (66)  ·  Infections (65)  ·  Bronchitis (63)  ·  Disease Attributes (58)  ·  Respiratory Tract Infections (52)  ·  Chronic Disease (49)

Interventions

montelukast (45)  ·  Fluticasone (40)  ·  Albuterol (37)  ·  Budesonide (28)  ·  Fluticasone-Salmeterol Drug Combination (28)  ·  Omalizumab (19)  ·  Salmeterol Xinafoate (15)  ·  Beclomethasone (12)  ·  Formoterol Fumarate (11)  ·  Azithromycin (9)  ·  Ipratropium (9)  ·  Mometasone Furoate (9)  ·  Prednisolone (9)  ·  Saline Solution (8)  ·  Budesonide, Formoterol Fumarate Drug Combination (7)

Sponsors

GlaxoSmithKline (47)  ·  AstraZeneca (21)  ·  Organon and Co (17)  ·  University of Saskatchewan (11)  ·  University of Dundee (10)  ·  Centre of Chinese Medicine, Georgia (8)  ·  Imperial College London (6)  ·  Novartis (6)  ·  Novartis Pharmaceuticals (6)  ·  Sanofi (6)  ·  Boehringer Ingelheim (5)  ·  Johns Hopkins University (5)  ·  Medical University of Lodz (5)  ·  University of Zurich (5)  ·  Children's Hospital of Philadelphia (4)

Countries

United States (126)  ·  United Kingdom (51)  ·  Canada (46)  ·  Germany (31)  ·  Italy (25)  ·  Spain (25)  ·  Netherlands (23)  ·  Belgium (22)  ·  France (18)  ·  Denmark (16)  ·  China (15)  ·  Poland (15)  ·  Sweden (13)  ·  Argentina (9)  ·  Australia (9)

Top investigators

Don Cockcroft, MD (6)  ·  Manana Tchaia, MD (6)  ·  Merab Lomia, MD, PhD (6)  ·  Konrad E Bloch, MD (5)  ·  Adam T Hill, MBChB MD (4)  ·  Brian Lipworth, MD (4)  ·  Leslie Hendeles, PharmD (4)  ·  Tamara Tchelidze, MD (4)  ·  C H Razi, MD (3)

Results publications

PMID 20167147, PMID 32298853, PMID 33369570, PMID 34433773, PMID 36472162, PMID 37347518, PMID 37536444, PMID 37952772, PMID 11511368, PMID 12045120, PMID 12095178, PMID 12403874, PMID 12612294, PMID 1285737, PMID 12927665, PMID 15229100, PMID 15672845, PMID 15741443, PMID 15922813, PMID 16113473, PMID 16597501, PMID 16687712, PMID 17035697, PMID 17046300, PMID 17053496, PMID 17075269, PMID 17507702, PMID 17610727, PMID 17629923, PMID 17652648, PMID 17766511, PMID 18006882, PMID 18025315, PMID 18583517, PMID 18828160, PMID 18990678, PMID 19127072, PMID 19134016, PMID 19164187, PMID 19208459, PMID 19291931, PMID 19467341, PMID 19496252, PMID 19541717, PMID 19557208, PMID 19632710, PMID 19663124, PMID 19696440, PMID 19804441, PMID 19808130

NIH funding

2019 (4), 2015 (3), 2017 (3), 2014 (2), 2016 (2), R01AT007987 (2), 2005 (1), 2009 (1), 2018 (1), N01MH090003 (1), P50HL056385 (1), P50HL084945 (1), R01DK109914 (1), R01HL114899 (1), R18HL092862 (1)